We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$41.7B
AUM Growth
+$4.68B
Cap. Flow
+$1.86B
Cap. Flow %
4.46%
Top 10 Hldgs %
38.45%
Holding
1,749
New
38
Increased
489
Reduced
263
Closed
22

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$197M
2
AMZN icon
Amazon
AMZN
+$197M
3
TMUS icon
T-Mobile US
TMUS
+$182M
4
UBER icon
Uber
UBER
+$180M
5
JNJ icon
Johnson & Johnson
JNJ
+$156M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$110M
2
MRK icon
Merck
MRK
+$108M
3
TEAM icon
Atlassian
TEAM
+$93.8M
4
CMCSA icon
Comcast
CMCSA
+$92.5M
5
WDAY icon
Workday
WDAY
+$86.7M

Sector Composition

Rank Sector Weight
1 Technology 35.61%
2 Communication Services 14.16%
3 Financials 13.31%
4 Healthcare 11.78%
5 Consumer Discretionary 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
1626
GeneDx Holdings
WGS
$2.31B
$54K ﹤0.01%
503
BCRX icon
1627
BioCryst Pharmaceuticals
BCRX
$2.37B
$53K ﹤0.01%
6,947
GTY
1628
Getty Realty Corp
GTY
$2.07B
$53K ﹤0.01%
1,983
PPTA
1629
Perpetua Resources
PPTA
$3.1B
$53K ﹤0.01%
+2,617
New +$44.2K
SDGR icon
1630
Schrodinger
SDGR
$1.36B
$53K ﹤0.01%
2,650
SLVM icon
1631
Sylvamo
SLVM
$1.63B
$53K ﹤0.01%
1,202
VITL icon
1632
Vital Farms
VITL
$541M
$53K ﹤0.01%
+1,278
New +$55.5K
APLS
1633
DELISTED
Apellis Pharmaceuticals
APLS
$52K ﹤0.01%
2,313
ARR
1634
Armour Residential REIT
ARR
$2.37B
$52K ﹤0.01%
3,465
ATRC icon
1635
AtriCure
ATRC
$2.08B
$52K ﹤0.01%
1,484
ENOV icon
1636
Enovis
ENOV
$1.53B
$52K ﹤0.01%
1,708
PBI icon
1637
Pitney Bowes
PBI
$2.39B
$52K ﹤0.01%
4,538
ROG icon
1638
Rogers Corp
ROG
$2.4B
$52K ﹤0.01%
644
CCS icon
1639
Century Communities
CCS
$2.04B
$51K ﹤0.01%
800
CDNA icon
1640
CareDx
CDNA
$2.4B
$51K ﹤0.01%
3,526
+2,492
+241% +$35.5K
HRMY icon
1641
Harmony Biosciences
HRMY
$2.26B
$51K ﹤0.01%
1,844
MBLY icon
1642
Mobileye
MBLY
$2.21B
$51K ﹤0.01%
3,615
NEO icon
1643
NeoGenomics
NEO
$2.11B
$51K ﹤0.01%
6,557
NSP icon
1644
Insperity
NSP
$2.02B
$51K ﹤0.01%
1,045
PCT icon
1645
PureCycle Technologies
PCT
$1.46B
$51K ﹤0.01%
3,847
PRGS icon
1646
Progress Software
PRGS
$1.76B
$51K ﹤0.01%
1,161
WERN icon
1647
Werner Enterprises
WERN
$2.24B
$51K ﹤0.01%
1,934
XHR
1648
Xenia Hotels & Resorts
XHR
$1.8B
$51K ﹤0.01%
3,699
BHE icon
1649
Benchmark Electronics
BHE
$2.96B
$50K ﹤0.01%
1,292
DFIN icon
1650
Donnelley Financial Solutions
DFIN
$1.17B
$50K ﹤0.01%
969

Similar funds

KBC Group's Q3 2025 Portfolio in Review

As of Q3 2025, KBC Group held 1,749 positions worth $41.7B, up 13% from $37B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

KBC Group deployed $1.86B of net new capital in Q3 2025, opening 38 new positions and adding to 489 existing holdings. Its largest new stake was Kinross Gold: 12,303 shares worth $306K.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was IBM, an estimated $110M trimmed.

  • KBC Group's largest Q3 2025 buy was Kinross Gold: 12,303 shares worth $306K.
  • KBC Group added most to Meta Platforms (Facebook) in Q3 2025, an estimated $197M increase.
  • KBC Group's biggest Q3 2025 reduction was IBM, cutting an estimated $110M.
  • KBC Group fully exited Ansys in Q3 2025, selling an estimated $26.9M.
  • KBC Group's ten largest holdings make up 38% of its $41.7B portfolio in Q3 2025.
  • KBC Group opened 38 new positions and closed 22 in Q3 2025.
  • KBC Group's portfolio value rose 13% quarter-over-quarter to $41.7B.

Based on KBC Group's 13F filing for Q3 2025, filed 20 Jan 2026.